Related Experiment Videos
MECP2 mutation analysis in patients with mental retardation
Tero Ylisaukko-Oja1, Karola Rehnström, Raija Vanhala
1Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland. tero.ylisaukko-oja@ktl.fi
American Journal of Medical Genetics. Part A
|December 4, 2004
Summary
Mutations in the methyl-CpG-binding protein 2 (MECP2) gene are not a major cause of nonspecific intellectual disability in males. This study found no causal MECP2 variants in 118 patients with intellectual disability.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
Background:
- Mutations in the methyl-CpG-binding protein 2 (MECP2) gene cause Rett syndrome, a common cause of intellectual disability (ID) in girls.
- MECP2 mutations have also been linked to various neurodevelopmental conditions, including autism and atypical Angelman syndrome.
- Previous studies suggested MECP2 mutations might account for up to 2% of male cases with nonspecific ID, comparable to Fragile X syndrome.
Purpose of the Study:
- To investigate the role of MECP2 gene mutations in the etiology of intellectual disability (ID) and atypical Angelman syndrome.
- To analyze well-characterized cases with ID to clarify the frequency and significance of MECP2 mutations.
Main Methods:
- Direct sequencing of the MECP2 gene's coding sequence in a cohort of 118 patients (103 males, 15 females) with ID.
- Identification and analysis of coding sequence variants and variants in intronic or 3'UTR regions.
Main Results:
- Two coding sequence variants (602C > T (A201V) and 1189G > A (E397K)) were identified in the MECP2 gene.
- Four additional variants were found in intronic or 3'UTR regions.
- None of the identified variants were deemed likely to be causal for the patients' condition.
Conclusions:
- The findings suggest that MECP2 mutations are not a major cause of nonspecific intellectual disability.
- Further research may be needed to fully elucidate the genetic underpinnings of ID and atypical Angelman syndrome.